Monthly Archives: August 2021

//August

PQS: Inhaler disposal quality criterion – are you ready to start working towards this from tomorrow?

Community pharmacy contractors are reminded that if they intend to meet the Respiratory domain of the Pharmacy Quality Scheme (PQS), they must start working towards the ‘Return of unwanted and unused inhalers’ quality criterion from tomorrow (1st September 2021) and continue with this until 31st January 2022. The quality criterion states: On the day of the declaration,...

By |August 31st, 2021|Lexpos News|Comments Off on PQS: Inhaler disposal quality criterion – are you ready to start working towards this from tomorrow?

Adjusted price for Cetirizine 1mg/ml oral solution sugar free following price changes in August 2021

During the month of August 2021, PSNC received several reports from contractors unable to obtain Cetirizine 1mg/ml oral solution sugar free (200ml) at the published Drug Tariff price of £6.49. PSNC submitted a request for a price concession but this was later withdrawn after confirmation from the Department of Health and Social Care (DHSC) that,...

By |August 27th, 2021|Lexpos News|Comments Off on Adjusted price for Cetirizine 1mg/ml oral solution sugar free following price changes in August 2021

End to temporary suspension of signatures on prescription forms and token submission requirements

On 31 August 2021, the temporary suspension of the need for signatures on prescription forms and/or EPS tokens comes to an end, ten months after it was first introduced. This will also mean an end to the temporary suspension of the requirement to submit certain EPS tokens to the NHS Business Services Authority (NHSBSA). As...

By |August 27th, 2021|Lexpos News|Comments Off on End to temporary suspension of signatures on prescription forms and token submission requirements

Inclisiran (Leqvio®) added to a new section of the Drug Tariff (Part VIIIC)

From September 2021, the Drug Tariff includes a new section, Part VIIIC, which sets out arrangements of payment for products with a nominal price (i.e where the purchase price of the product is significantly lower than its NHS list price).  Products listed in Part VIIIC are available at nominal prices because of commercial deals in...

By |August 27th, 2021|Lexpos News|Comments Off on Inclisiran (Leqvio®) added to a new section of the Drug Tariff (Part VIIIC)

Drug Tariff Watch – September 2021

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a quick summary of the changes coming into effect from 1 September 2021. From September 2021, the Drug Tariff includes a new section, Part VIIIC, which sets out arrangements of payment for products with...

By |August 27th, 2021|Lexpos News|Comments Off on Drug Tariff Watch – September 2021